🍪 CompoundTalk uses cookies to improve your experience, analyze traffic, and personalize content. By continuing to use this site, you agree to our Cookie Policy.
Evidence-based GLP-1 & peptide discussion since 2023
ForumsSemaglutide (Ozempic / Wegovy)Semaglutide cardiovascular benefit: SELECT trial deep dive — looking for input Page 11

Semaglutide cardiovascular benefit: SELECT trial deep dive — looking for input

MaxMetOK Tue, Dec 17, 2024 at 2:04 PM 56 replies 2,950 viewsPage 11 of 12
cory_ATX
Member
456
2,123
Jul 2024
Austin, TX
Feb 3, 2025 at 11:46 AM#51
DataDave said:
CRP reduction on cardiovascular risk — this is the lab result that excites me most: Baseline hsCRP: 8.0 mg/L (high cardiovascular risk) Month 6 hsCRP:…
DataDave said:
...we don't know the long-term effects of cardiovascular risk...

This is a fair point, and I think intellectual honesty requires acknowledging it. GLP-1 agonists in their current form have ~8-10 years of human exposure data. That's not nothing, but it's not 30+ years either.

However: the risk-benefit calculation should also consider the KNOWN long-term effects of untreated obesity — diabetes, cardiovascular disease, cancer, joint destruction, reduced lifespan by 5-10 years.

Uncertainty about GLP-1 long-term safety vs certainty about obesity consequences. The calculus seems clear to me, but reasonable people can disagree.

5 3Dr.EndoEP, GraceAZ_72, carl_compliance and 2 others
Reply Quote Save Share Report
greg_boulder
Member
345
1,567
Jul 2024
Boulder, CO
Feb 4, 2025 at 6:37 PM#52
DataDave said:
CRP reduction on cardiovascular risk — this is the lab result that excites me most: Baseline hsCRP: 8.0 mg/L (high cardiovascular risk) Month 6 hsCRP:…

Thank you for spelling out the reasoning rather than just the conclusion. I will report back once I have actually tried it.

6 4fiona_VT, denise_HTX, raj_cambridge and 3 others
Reply Quote Save Share Report
ingrid_STO
Member
345
1,456
Jul 2024
Stockholm, SE
Feb 6, 2025 at 1:27 AM#53

Adding the clinical framing, because it changes how the question reads. The version of this that has an answer is narrower than the version being asked. Narrow it and it becomes tractable; leave it broad and the thread will produce nine confident and incompatible replies.

Ask again with the specifics and you will get a better answer than this one.

Last edited: Feb 6, 2025 at 4:27 AM
7 5MikeFit_NJ, InsuranceTom, WendyG_ATL and 4 others
Reply Quote Save Share Report

PeptideMeter — Independent Peptide Analytics

Community-driven peptide testing and vendor rating platform. Transparent results. Unbiased analysis. Trusted by thousands.

View Results
HealthEcon_DC
Member
567
3,456
Apr 2024
Washington, DC
Feb 7, 2025 at 8:16 AM#54
ingrid_STO said:
The version of this that has an answer is narrower than the version being asked.

Can confirm. Same sequence, different timescale. Posting only so the count is not one.

Last edited: Feb 7, 2025 at 10:16 AM
8 6TirzTom, TrialTracker_MD, JennaRN and 5 others
Reply Quote Save Share Report
PedsEndoPhilly
Member
345
1,890
Jun 2024
Philadelphia, PA
Feb 8, 2025 at 3:04 PM#55
ingrid_STO said:
The version of this that has an answer is narrower than the version being asked.

Adding the part of the answer the thread has not reached. There is a difference between no evidence and evidence of no effect, and this subject is one where the two get swapped freely in both directions.

Worth separating that from semaglutide, which this thread keeps folding into the same question. They behave differently and the advice does not transfer.

Last edited: Feb 8, 2025 at 8:04 PM
9 7MikeNYC_runner and 6 others
Reply Quote Save Share Report

Similar Threads

STEP 1-5 trials comprehensive summary — efficacy endpoints compiled12 replies
Oral semaglutide 50mg Phase 3 — OASIS program results16 replies
Semaglutide pharmacokinetics — half-life, Tmax, steady state modeling10 replies
Compounded semaglutide stability data — temperature and light sensitivity16 replies
0.25mg → 2.4mg titration: optimal schedule based on clinical data6 replies
ForumsNewTrendingMembersAccount

Log In

Forgot password?
No account? Register